Hongru Yang
- Co-authors
- Yumeng WeiChao PiLing ZhaoXiaoli ZhengHao LiuJing LiangTing FengShousong Cao
- Topics
- Curcumin's Biomedical Applications (9 papers)Nanoparticle-Based Drug Delivery (5 papers)COVID-19 Clinical Research Studies (4 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Hongru Yang
29 papers receiving 548 citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 195
- Molecular Medicine 115
- Pharmacology 90
- Biomaterials 86
- Oncology 61
Countries citing papers authored by Hongru Yang
This map shows the geographic impact of Hongru Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongru Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongru Yang more than expected).
Fields of papers citing papers by Hongru Yang
This network shows the impact of papers produced by Hongru Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongru Yang. The network helps show where Hongru Yang may publish in the future.
Co-authorship network of co-authors of Hongru Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Hongru Yang. A scholar is included among the top collaborators of Hongru Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongru Yang. Hongru Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 15 | |
| 3 | 10 | |
| 4 | 2 | |
| 5 | 9 | |
| 6 | 17 | |
| 7 | 42 | |
| 8 | 20 | |
| 9 | 16 | |
| 10 | 37 | |
| 11 | 50 | |
| 12 | 16 | |
| 13 | 28 | |
| 14 | 3 | |
| 15 | 6 | |
| 16 | 74 | |
| 17 | 56 | |
| 18 | 18 | |
| 19 | 21 | |
| 20 | 10 |
About Hongru Yang
Hongru Yang is a scholar working on Molecular Medicine, Biomaterials and Cancer Research, having authored 29 papers that have together received 556 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (9 papers), Nanoparticle-Based Drug Delivery (5 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Molecular Medicine (115 citations), Pharmaceutical Science (49 citations) and Biomaterials (86 citations). Hongru Yang has collaborated with scholars based in China and United States. Frequent co-authors include Yumeng Wei, Chao Pi, Ling Zhao, Xiaoli Zheng, Hao Liu, Jing Liang, Ting Feng, Shousong Cao, Qin Zhou and Shaozhi Fu. Their work appears in journals such as Scientific Reports, International Journal of Radiation Oncology*Biology*Physics and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.